We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Bivictrix Therapeutics Limited

Bivictrix Therapeutics Limited

BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.


  • Funded
    status
  • £451,506
    raised of £430,000 goal
  • Funded
    11 Aug 2016
  • 10
    investors
  • £4,347,778
    pre-money valuation

  • Platform
  • Medical EIS SEIS
View on nextfin.uk may earn a commission from partners

Please sign in or register to nextfin.uk to comment on this pitch.

Sign In Register

Other pitches in Medical


  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph